274 related articles for article (PubMed ID: 27080848)
1. Pharmacovigilance, risks and adverse effects of self-medication.
Montastruc JL; Bondon-Guitton E; Abadie D; Lacroix I; Berreni A; Pugnet G; Durrieu G; Sailler L; Giroud JP; Damase-Michel C; Montastruc F
Therapie; 2016 Apr; 71(2):257-62. PubMed ID: 27080848
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions to self-medication: a study in a pharmacovigilance database.
Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL
Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication.
Gras M; Gras-Champel V; Moragny J; Delaunay P; Laugier D; Masmoudi K; Liabeuf S
Ann Pharm Fr; 2021 Sep; 79(5):522-529. PubMed ID: 33631179
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance implemented by patients: A necessity in the 21st century.
Lafond J
Therapie; 2016 Apr; 71(2):245-7. PubMed ID: 27080846
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacovigilance of self-medication].
Montastruc JL; Bagheri H; Geraud T; Lapeyre-Mestre M
Therapie; 1997; 52(2):105-10. PubMed ID: 9231503
[TBL] [Abstract][Full Text] [Related]
6. Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review.
Locquet M; Honvo G; Rabenda V; Van Hees T; Petermans J; Reginster JY; Bruyère O
Drugs Aging; 2017 May; 34(5):359-365. PubMed ID: 28247317
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M
Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoepidemiology and its input to pharmacovigilance.
Faillie JL; Montastruc F; Montastruc JL; Pariente A
Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
[TBL] [Abstract][Full Text] [Related]
10. Medication errors through a national pharmacovigilance database approach: a study for Malta.
Tanti A; Camilleri M; Bonanno PV; Borg JJ
Int J Risk Saf Med; 2013 Jan; 25(1):17-27. PubMed ID: 23442294
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System.
Nogueira Guerra L; Herdeiro MT; Ribeiro-Vaz I; Clérigo MI; Rocha C; Araújo A; Pêgo A; Rebelo Gomes E
Expert Opin Drug Saf; 2015; 14(12):1805-13. PubMed ID: 26549822
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
13. Drugs and Sleep Apneas? A review of the French Pharmacovigilance database.
Linselle M; Montastruc F; Jantzen H; Valnet-Rabier MB; Haramburu F; Coquerel A; Gouraud A; Perault-Pochat MC; Bagheri H; Montastruc JL
Therapie; 2015; 70(4):347-50. PubMed ID: 25679185
[TBL] [Abstract][Full Text] [Related]
14. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of self medication.
Hughes CM; McElnay JC; Fleming GF
Drug Saf; 2001; 24(14):1027-37. PubMed ID: 11735659
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacovigilance update].
Dao K; Chtioui H; Rothuizen LE; Diezi L; Prod'hom S; Winterfeld U; Buclin T; Livio F
Rev Med Suisse; 2016 Jan; 12(500):75-9. PubMed ID: 26946710
[TBL] [Abstract][Full Text] [Related]
17. Risks of self-medication practices.
Ruiz ME
Curr Drug Saf; 2010 Oct; 5(4):315-23. PubMed ID: 20615179
[TBL] [Abstract][Full Text] [Related]
18. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
19. The contribution of pharmacogenetics to pharmacovigilance.
Bondon-Guitton E; Despas F; Becquemont L
Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
